Concepedia

Margaretta Nyilas

MN

17

Publications

2.1K

Citations

16

H-Index

2006

Active since

Affiliations

Otsuka (United States)(Current)

Lundbeck (Denmark)

Bristol-Myers Squibb (United States)

Bristol-Myers Squibb (Germany)

Otsuka (Japan)

Margaretta Nyilas is an author at Otsuka (United States) specializing in pharmacotherapy, medicine, and psychiatry.

Top concepts

Publications per year

2006–2018

17

Publications

17

A multicenter, randomized, double-blind, controlled phase 3 trial of fixed-dose brexpiprazole for the treatment of adults with acute schizophrenia

John M. Kane, Aleksandar Skuban, John Ouyang et al. · Schizophrenia Research · 2015 · 322 citations

, , +10

A Multiple-Center, Randomized, Double-Blind, Placebo-Controlled Study of Oral Aripiprazole for Treatment of Adolescents With Schizophrenia

Robert L. Findling, Adelaide S. Robb, Margaretta Nyilas et al. · American Journal of Psychiatry · 2008 · 265 citations

Acute Treatment of Pediatric Bipolar I Disorder, Manic or Mixed Episode, With Aripiprazole

Robert L. Findling, Margaretta Nyilas, Robert A. Forbes et al. · The Journal of Clinical Psychiatry · 2009 · 224 citations

Efficacy and Safety of Brexpiprazole for the Treatment of Acute Schizophrenia: A 6-Week Randomized, Double-Blind, Placebo-Controlled Trial

Christoph U. Correll, Aleksandar Skuban, John Ouyang et al. · American Journal of Psychiatry · 2015 · 178 citations

Efficacy and Safety of Adjunctive Brexpiprazole 2 mg in Major Depressive Disorder

Michael E. Thase, James M. Youakim, Aleksandar Skuban et al. · The Journal of Clinical Psychiatry · 2015 · 171 citations

Rows per page

1–5 of 17